Skip to main content

Developing Countries: Coronavirus

Question for Foreign, Commonwealth and Development Office

UIN HL10635, tabled on 23 November 2020

To ask Her Majesty's Government what steps they are taking to provide equitable access to COVID-19 vaccines for those living in the global south.

Answered on

26 November 2020

This answer is a correction from the original answer.

The UK is committed to rapid, equitable access to safe and effective vaccines as demonstrated by our strong support for the Access for COVID-19 Tools (ACT) Accelerator. The UK has contributed up to £813 million to the ACT-Accelerator partners. This includes the UK's commitment of up to £548 million to the COVAX Advance Market Commitment (AMC) - the international initiative to support global equitable access to vaccines, of which the UK is the largest bilateral donor. Our commitment to the COVAX AMC will support access to COVID-19 vaccines for up to 92 developing countries by contributing to the supply of 1 billion doses in 2021, and vaccinations for up to 500 million people (subject to vaccines successfully securing stringent regulatory approvals).

Original answer

The UK is committed to rapid, equitable access to safe and effective vaccines as demonstrated by our strong support for the Access for COVID-19 Tools (ACT) Accelerator. The UK has contributed up to £813 million to the ACT-Accelerator partners. This includes the UK's commitment of up to £548 million to the COVAX Advance Market Commitment (AMC) - the international initiative to support global equitable access to vaccines, of which the UK is the largest bilateral donor. Our commitment to the COVAX AMC will support access to COVID-19 vaccines for up to 92 developing countries by contributing to the supply of 1 billion doses in 2021, and vaccinations for up to 500 million people (subject to vaccines successfully securing stringent regulatory approvals).